We are live on
!
Find out more
Royalty Pharma
RPRX
RPRX
134 hedge funds and large institutions have $6.52B invested in Royalty Pharma in 2020 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 47 increasing their positions, 18 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
161% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 18
28% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 39
9% more funds holding
Funds holding: 123 → 134 (+11)
2.5% more ownership
Funds ownership: 41.04% → 43.53% (+2.5%)
7% less capital invested
Capital invested by funds: $7.04B → $6.52B (-$514M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
19% less call options, than puts
Call options by funds: $5.21M | Put options by funds: $6.43M
Holders
134
Holders Change
+11
Holders Change %
+8.94%
% of All Funds
2.7%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.12%
New
50
Increased
47
Reduced
18
Closed
39
Calls
$5.21M
Puts
$6.43M
Net Calls
-$1.22M
Net Calls Change
-$2.3M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$136M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$96M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$78.6M |
| 4 |
BlackRock
New York
|
+$72.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$41.9M |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
-$67.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$36.7M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$34.5M |
| 4 |
Millennium Management
New York
|
-$29.1M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$24.3M |
